Depression in Late Life

Similar documents
A Basic Approach to Mood and Anxiety Disorders in the Elderly

Pharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD

Psychotropic Medication Use in Dementia

9/24/2012. Amer M Burhan, MBChB, FRCP(C)

Psychiatry in Primary Care: What is the Role of Pharmacist?

Depression: selective serotonin reuptake inhibitors

VA/DOD CLINICAL PRACTICE GUIDELINE

DIAGNOSTIC CRITERIA (ICD 10)

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.

Recognizing Depression and Restoring Mood and Well- Being in the Older Patient

Medication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford

Mood Disorders.

Family Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University

Adult Depression - Clinical Practice Guideline

Anti-Depressant Medications

Depression Workshop 26 January 2007

Depression & Anxiety in Adolescents

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

1/3/2017 DEPRESSION IN THE OLDER PATIENT: EVALUATION AND MANAGEMENT

DEPRESSION IN THE OLDER PATIENT: EVALUATION AND MANAGEMENT

DEMENTIA AND MEDICATION


Disclosure Information

Geriatric Depression Diagnosis and Treatment. Disclosures. Objectives 11/4/2018. None

Depression in Older Adults. Paul Boulware, MD Arizona Neurological Institute April 22, 2012

SUTTER PHYSICIANS ALLIANCE (SPA) 2800 L Street, 7 th Floor Sacramento, CA 95816

Optimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE

Depression: Identification, Evaluation and Management in Primary Care

Presentation is Being Recorded

Advances in Diagnosis, Neurobiology, and Treatment of Mood Disorders

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded

Guilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant.

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Depression in the Eldery Handout Package

Depression major depressive disorder. Some terms: Major Depressive Disorder: Major Depressive Disorder:

Lewy Body Disease. Dementia Education for the First Responder July 27, 2017

48 th Annual Meeting. Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5. Disclosure. Depression. Patient Case. Objectives 7/19/2014

Introduction to Drug Treatment

Life is a miserable thing. I have decided to spend my life thinking about it. Irvin D. Yalom, The Schopenhauer Cure

Presenter Disclosure. Objectives 6/5/2017. Depression, Anxiety, PTSD: A Focus on Pharmacotherapy

Partners in Care Quick Reference Cards

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment

Index. Bulimia, 13 Bupropion, 12, 51 Buspirone, 81

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY

Depression. Depression. What is it all about? Social and economic burden of depression

Objectives. Objectives. A practice review. 02-Nov-16 MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS

Quick Guide to Common Antidepressants-Adults

MEDICATION ALGORITHM FOR ANXIETY DISORDERS

controls past MDD current MDD

Depression & Suicide 7/11/2017 DISCLOSURES. DSM 5 Depressive Disorders. Objectives

Realities of Depression in Primary Care Setting

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

Geriatric Depression; Not a Normal Part of Growing Older. Cherie Warriner, LCSW

Non-A, non-b=hcv; IFN/RBV; DSM-5/Ham-D, OLT; SSRI, P450

Effective Health Care

Drugs for Emotional and Mood Disorders Chapter 16

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

PSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Behavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.

Depression. University of Illinois at Chicago College of Nursing

DEPRESSION An introduction to aging science brought to you by the American Federation for Aging Research

How to treat depression with medication: Some rules of thumb

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

8/15/14. Julie Wood, MD Southwestern Behavioral Healthcare & Mulberry Memory Clinic

Treatment-resistant depression in primary care

Children s Hospital Of Wisconsin

Mentoring Session: Participant Cases

Management of Behavioral Problems in Dementia

Depression in adults: treatment and management

Didactic Series. Depression in HIV/AIDS

Managing Late Life Depression

Antidepressants. Dr Malek Zihlif

Treatment of Mood Disorders in Midlife Women

Clinical Perspective on Conducting TRD Studies. Hans Eriksson, M.D., Ph.D., M.B.A. Chief Medical Specialist, H. Lundbeck A/S Valby, Denmark

Kelly Godecke, MD Department of Psychiatry University of Utah

VA/DoD Clinical Practice Guideline for Management of Post Traumatic Stress. Core Module

Disclosures. Overview of Workshop. Objectives. Medical Care of Vulnerable and Underserved Populations: Advanced Cases in Anxiety and Depression

Psychiatry curbside: Answers to a primary care doctor s top mental health questions

Augmentation and Combination Strategies in Antidepressants treatment of Depression

Antidepressant Selection in Primary Care

Strategies for Diagnosing and Treating Depressive Disorders in Primary Care

Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults

Consultant Pharmacist Approach to Major Depressive Disorder

Consultant Pharmacist Approach to Major Depressive Disorder ALAN OBRINGER RPH, CPH, CGP PRESIDENT/OWNER GUARDIAN PHARMACY OF ORLANDO

Clinical Guideline for the Management of Bipolar Disorder in Adults

The Pharmacist's Role in Major Depressive Disorder: Optimizing Care. Welcome We will begin shortly.

Anxiety and Depression Management for General Providers

BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA

Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Mixing and Matching: Layering Medications as Family Physicians

Pharmacological Treatment of Anxiety & Depressive Disorders

DISEASES AND DISORDERS

Treatment Options for Bipolar Disorder Contents

Transcription:

Depression in Late Life Robert Madan MD FRCPC Geriatric Psychiatrist

Key Learnings Robert Madan MD FRCPC

Key Learnings By the end of the session, participants will be able to List the symptoms of depression List 3 treatment modalities List 3 side effects of antidepressants in the elderly 3

Outline Common Causes Assessment Management Implications for Practice 4

Prevalence of Geriatric Depression 4.4% in women, 2.7% in men for Major Depression (Cache County 2000) Sub threshold depression = 31.1% Worsens quality of life and health Increased service utilization and cost expenditure 5

Common Causes Robert Madan MD FRCPC 6

Biopsychosocial Biological Factors Genetics and medical illness Psychological vulnerability Social Circumstances E.g., loss, moving, retirement 7

Conditions Associated with Late Life Depression Arthritis Sensory loss Urinary tract/prostate disease Obesity Chronic Pain Diabetes Cerebrovascular disease Silent infarct Parkinson's Myocardial infarction CAD Cardiac catheterization 8

Medications Associated with Late Life Depression Cimetidine Clonidine Hydralazine Estrogens Progesterone Tamoxifen Vinblastine Vincristine 9 Methyldopa Benzodiazepines Propranolol Reserpine Steroids Anti-Parkinsonian agents Beta- blockers

Vascular Depression Depression executive dysfunction syndrome Disruption of frontal-striatal circuits Symptoms Apathy Anhedonia Executive dysfunction Psychomotor retardation Poor response to Rx 10

Depression and Dementia Early and late-onset Depression increases the risk of dementia 2 meta analyses (Jorm 2001, Ownby 2006) Case control and prospective studies Risk increases 2-fold 11

Hypotheses 1. Depression causes hippocampal damage 2. Prodrome to dementia 3. Depression as neuropsychiatric symptoms of dementia 4. Dementia and depression have common risk factors (vascular) 5. Depression as a reaction to dementia 12

Assessment Robert Madan MD FRCPC 13

Differential Diagnosis Major Depressive Disorder Bipolar Depression Persistent Depressive Disorder (dysthymia) Adjustment Disorder with Depressed Mood Substance/Medication Induced Depressive Disorder Depressive Disorder due to Another Medical Condition Bereavement 14

Symptoms of Major Depression *Depressed/empty *Anhedonia Sleep (less or more) Appetite (less or more) Reduced energy Poor concentration Guilt or worthlessness Psychomotor slowing or restlessness Thoughts of death or suicide Distress or impairment in functioning X 2 weeks 15

Symptoms of Major Depression S: sleep I: interest G: guilt/worthlessness E: energy C: concentration A: appetite P: psychomotor S: suicidal thoughts 16

Presentation More likely Anhedonia Cognitive complaints Somatic symptoms Vegetative symptoms Irritability Social withdrawal Less likely depressed mood Guilt/worthlessness 17

Subtypes Depression with psychotic features Hallucinations Delusions Depression with seasonal pattern Depression with anxious distress 18

Anxious Depression Anxious Distress: 2 of: keyed up/tense, restless, concentration, fear that something awful will happen, feelings of losing control Compared to non-anxious depression Predicts cognitive decline Predicts suicide risk Poor prognosis Treatment implications 19

Bereavement Feelings of emptiness and loss Waves or pangs that decrease over days to weeks; assoc with reminders Can have positive emotions or humour Thoughts about deceased Self-esteem preserved Join the deceased 20

Assessment Collateral History Safety Physical exam Bloodwork CBC, Lytes, Thyroid, B12, Calcium Imaging Driving 21

Rating Scales Geriatric Depression Scale 15 item PHQ -9 - Patient Health Questionnaire MADRS Montgomery Asperg Depression Scale Beck Depression Inventory 22

Management Robert Madan MD FRCPC 23

Treatment Pharmacotherapy Psychotherapy Other somatic treatments 24

Start low and go slow Start at ¼ to ½ the usual adult starting dose Increase the dose slowly, in small increments Example Citalopram 10mg starting dose (or 5 mg in some..) and increase by 10 mg increments 25

Antidepressants Response rates 48%, remission 33.7% a Evidence from Randomized Placebo Controlled Trials exists for: Fluoxetine Paroxetine Sertraline Duloxetine 26

Maintenance Maintenance studies NNT to prevent 1 recurrence in 2 years is 4 Recurrence rates are high; up to 90% in 3 years in 1 seminal study 27

Serotonin Reuptake Inhibitors Sertraline (25-200mg) Citalopram (Qtc) (5-20mg) Escitalopram (Qtc) (5-10mg) Paroxetine (drug interactions, anticholinergic) 10-40mg Fluoxetine (drug interactions) (10-40mg) Fluvoxamine (drug interactions) (25-200mg) 28

Other Antidepressants SNRIs: venlafaxine (37.5-300mg), duloxetine (30-120mg) Hyponatremia, hypertension, orthostatic hypotension) Bupropion SR/XL (100-450mg) Drug interactions, tremor, agitation Mirtazapine (7.5-45mg) Anti-histaminic, very sedating, weight gain 29

Side Effects GI Bleeding SSRI Hyponatremia SSRI, SNRI Falls Qtc 30

Treatment resistant depression 2/3 do not remit with 1 trial Step 1 check adherence Adequate trial? 6 weeks at therapeutic dose If in partial remission Psychotherapy Pharmacotherapy 31

Augmentation Atypicals *Quetiapine XR (Katilla et al., 2013) Monotherapy Aripirazole Olanzapine, risperidone Lithium 0.4 to 0.8 mmol/l T3 Methylphenidate 32

Combinations Combine antidepressants with different mechanisms of action, never an MAOI Mirtazapine + SSRI, SNRI, TCA, bupropion Bupropion + SSRI, SNRI, TCA (drug interaction), mirtazapine TCA + SSRI 33

Electroconvulsive Therapy Procedure Efficacy Remission rates of 75% or higher in MDD Risks Meta-analysis of 2981 patients shows cognitive impairment 3 days post-treatment, improves above baseline by day 15 34

Psychotherapy Best evidence Cognitive Behavioural Therapy Problem Solving Therapy Interpersonal Therapy Group, family, supportive, dynamic 35

Implications for Practice Robert Madan MD FRCPC 36

Implications for Practice Depression is common in late life and has serious consequences Cognitive and Medical workup Treatment requires patience and persistence Watch for pharmacokinetic and pharmacodynamic drug interactions Multimodal treatment 37

Guidelines CCSMH Canadian Coalition for Seniors Mental Health http://www.ccsmh.ca/en/default.cfm 38

Thank you!